FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587996964> ?p ?o ?g. }

• W2587996964 abstract "Abstract Abstract 2047 Objectives: Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare acquired clonal hematopoietic stem cell disease. Patients may present with intermittent hemolysis, thrombotic events or cytopenias. The manifestations can be life threatening. Hematopoietic Cell Transplantation (HCT) is still the only curative therapy. Hegenbart et al reported early results in 7 patients with PNH with high risk features who received transplants from matched related (n=2) or unrelated donors (n=5) after conditioning with a fludarabine / total body irradiation (TBI) based regimen (Biol Blood Marrow Transplant 2003; 9: 689–697). Here we update the data and report outcomes in 12 additional patients. Patients: Nineteen patients diagnosed with severe PNH underwent allogeneic HCT after a reduced intensity conditioning (RIC) regimen. Patients were treated at 9 centers. Eighteen patients had at least 1 high-risk feature (Table), 1 patient had none but underwent transplant because of severe hemolysis prior to the era of eculizumab. Conditioning consisted of fludarabine (30 mg/m2/d) on days −4 to −2 before HCT and 2 Gy (n=16) or 4 Gy (n=3) of TBI on day 0 (n=16) followed by treatment with mycophenolate mofetil and cyclosporine or tacrolimus. All patients received peripheral blood stem cells (PBSC). Donors were HLA-matched related (n=3), HLA-matched unrelated (n=12) or HLA-mismatched unrelated (n=4). Results: The follow-up period ranges between 2 months and almost 10 years (median 27.5 months) after HCT. Neutropenia (absolute neutrophil count<500/μl) developed in 15 of 19 patients after transplantation. The median time to neutrophil recovery in patients who engrafted was 16 days (range 0–29) with a median duration of neutropenia of 12 days (range 0–17, n=12). The median duration of thrombocytopenia (platelet count <20,000/μl) was 3 days (range, 0 to 10 days, n=12). All but 2 patients (89.5%) had a sustained engraftment. One patient experienced primary graft failure and remained neutropenic. He received a second nonmyeloablative HLA-matched unrelated PBSC transplant, 47 days after the first transplant, from a different donor, with 3 Gy TBI and 90mg/m2 fludarabine, and had sustained engraftment. The second patient experienced after engraftment, late graft failure 6 months after HCT. She underwent, 7 months after the first transplant, a second nonmyeloablative, HLA- matched unrelated PBSC transplant, from a different donor, with 4 Gy TBI and 150mg/m2 fludarabine, and had sustained engraftment. Eighteen patients were assessable for acute graft-versus-host disease (GvHD). The incidence of grades 2, 3, and 4 acute GvHD were 22% (4/18), 17% (3/18), and 5% (1/18), respectively. Chronic GvHD developed in 78% (14/18) of evaluable patients. Fifteen patients (78.9%) are alive at the time of last follow-up (Fig.). None of the 15 patients still alive has any evidence of relapse, clinically nor by flow cytometry. Four patients died (21.1%) of complications (necrotizing pancreatitis of unknown cause, pseudomonas infection during treatment of chronic GvHD, hemorrhage after liver biopsy with subacute/chronic liver GvHD, intracerebral bleed). All 15 surviving patients have an ECOG performance status of 0 or 1. Conclusion: The RIC regimen reported here is well tolerated and leads to a high rate of successful engraftment. The graft-versus-host effect seems to be sufficient to eradicate the PNH clone. This regimen may be equally effective in medically fit PNH patients to eradicate the PNH clone while reducing treatment related complications of higher intensity conditioning regimens. Note: 1st 3 authors contributed equally. Disclosures: No relevant conflicts of interest to declare." @default.
• W2587996964 created "2017-02-24" @default.
• W2587996964 creator A5022581742 @default.
• W2587996964 creator A5045191576 @default.
• W2587996964 creator A5050114753 @default.
• W2587996964 creator A5055821837 @default.
• W2587996964 creator A5085787488 @default.
• W2587996964 creator A5087069801 @default.
• W2587996964 creator A5089494498 @default.
• W2587996964 date "2011-11-18" @default.
• W2587996964 modified "2023-10-01" @default.
• W2587996964 title "Hematopoietic Cell Transplantation After Reduced Intensity Conditioning for Severe Paroxysmal Nocturnal Hemoglobinuria:" @default.
• W2587996964 doi "https://doi.org/10.1182/blood.v118.21.2047.2047" @default.
• W2587996964 hasPublicationYear "2011" @default.
• W2587996964 type Work @default.
• W2587996964 sameAs 2587996964 @default.
• W2587996964 citedByCount "1" @default.
• W2587996964 countsByYear W25879969642012 @default.
• W2587996964 crossrefType "journal-article" @default.
• W2587996964 hasAuthorship W2587996964A5022581742 @default.
• W2587996964 hasAuthorship W2587996964A5045191576 @default.
• W2587996964 hasAuthorship W2587996964A5050114753 @default.
• W2587996964 hasAuthorship W2587996964A5055821837 @default.
• W2587996964 hasAuthorship W2587996964A5085787488 @default.
• W2587996964 hasAuthorship W2587996964A5087069801 @default.
• W2587996964 hasAuthorship W2587996964A5089494498 @default.
• W2587996964 hasConcept C111684460 @default.
• W2587996964 hasConcept C126322002 @default.
• W2587996964 hasConcept C141071460 @default.
• W2587996964 hasConcept C159654299 @default.
• W2587996964 hasConcept C203014093 @default.
• W2587996964 hasConcept C2776694085 @default.
• W2587996964 hasConcept C2776755627 @default.
• W2587996964 hasConcept C2777063308 @default.
• W2587996964 hasConcept C2777346216 @default.
• W2587996964 hasConcept C2777408962 @default.
• W2587996964 hasConcept C2777991916 @default.
• W2587996964 hasConcept C2778880498 @default.
• W2587996964 hasConcept C2779015954 @default.
• W2587996964 hasConcept C2779263901 @default.
• W2587996964 hasConcept C2911091166 @default.
• W2587996964 hasConcept C71924100 @default.
• W2587996964 hasConcept C74133956 @default.
• W2587996964 hasConcept C90924648 @default.
• W2587996964 hasConceptScore W2587996964C111684460 @default.
• W2587996964 hasConceptScore W2587996964C126322002 @default.
• W2587996964 hasConceptScore W2587996964C141071460 @default.
• W2587996964 hasConceptScore W2587996964C159654299 @default.
• W2587996964 hasConceptScore W2587996964C203014093 @default.
• W2587996964 hasConceptScore W2587996964C2776694085 @default.
• W2587996964 hasConceptScore W2587996964C2776755627 @default.
• W2587996964 hasConceptScore W2587996964C2777063308 @default.
• W2587996964 hasConceptScore W2587996964C2777346216 @default.
• W2587996964 hasConceptScore W2587996964C2777408962 @default.
• W2587996964 hasConceptScore W2587996964C2777991916 @default.
• W2587996964 hasConceptScore W2587996964C2778880498 @default.
• W2587996964 hasConceptScore W2587996964C2779015954 @default.
• W2587996964 hasConceptScore W2587996964C2779263901 @default.
• W2587996964 hasConceptScore W2587996964C2911091166 @default.
• W2587996964 hasConceptScore W2587996964C71924100 @default.
• W2587996964 hasConceptScore W2587996964C74133956 @default.
• W2587996964 hasConceptScore W2587996964C90924648 @default.
• W2587996964 hasLocation W25879969641 @default.
• W2587996964 hasOpenAccess W2587996964 @default.
• W2587996964 hasPrimaryLocation W25879969641 @default.
• W2587996964 hasRelatedWork W2132824197 @default.
• W2587996964 hasRelatedWork W2167584739 @default.
• W2587996964 hasRelatedWork W2398646277 @default.
• W2587996964 hasRelatedWork W2537106166 @default.
• W2587996964 hasRelatedWork W2549500579 @default.
• W2587996964 hasRelatedWork W2556592248 @default.
• W2587996964 hasRelatedWork W2575724167 @default.
• W2587996964 hasRelatedWork W2588362605 @default.
• W2587996964 hasRelatedWork W2591936344 @default.
• W2587996964 hasRelatedWork W2599243698 @default.
• W2587996964 hasRelatedWork W2625880017 @default.
• W2587996964 hasRelatedWork W2733050244 @default.
• W2587996964 hasRelatedWork W2902194034 @default.
• W2587996964 hasRelatedWork W2911771633 @default.
• W2587996964 hasRelatedWork W2979628503 @default.
• W2587996964 hasRelatedWork W2979734870 @default.
• W2587996964 hasRelatedWork W2980187995 @default.
• W2587996964 hasRelatedWork W2992959047 @default.
• W2587996964 hasRelatedWork W3030299667 @default.
• W2587996964 hasRelatedWork W3031349232 @default.
• W2587996964 isParatext "false" @default.
• W2587996964 isRetracted "false" @default.
• W2587996964 magId "2587996964" @default.
• W2587996964 workType "article" @default.